Global Reporter Gene Assay Market Segmentation, By Product (Assay Kits and Reagents), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, CROs) – Industry Trends and Forecast to 2032.
Global Reporter Gene Assay Market Analysis
Reporter gene assays are to be one of the most widely used cell-based assays for determining the biological role of target molecules. As a result, researchers prefer fluorescence assays for real-time analysis of dynamic processes in living cells. This is possible due to the availability of various coloured reporter gene modifications, as well as the fact that cell lysis or the addition of any kind of substrate is not required for quantification.
Global Reporter Gene Assay Market Size
Global reporter gene assay market size was valued at USD 724.05 million in 2024 and is projected to reach USD 1480.20 million by 2032, with a CAGR of 9.35% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Reporter Gene Assay Key Market Insights
|
|
Segmentation
|
By Product: Assay Kits and Reagents
By Application: Gene Regulation, Protein Interaction, Cell Signalling Pathways
By End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, CROs
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
Merck KGaA (Germany), Thermo Fisher Scientific Inc (U.S.), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Abcam plc. (U.K.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher (U.S.), Biotium (U.S.), PromoCell GmbH (Germany), InvivoGen (U.S.), Geno Technology Inc. (India), GeneCopoeia, Inc. (U.S.), Lonza (Switzerland), General Electric (U.S.), QIAGEN (Germany), Sartorius AG (Germany), Berthold Technologies GmbH & Co. KG (Germany), Marker Gene Technologies, Inc. (U.S.)
|
|
Market Opportunities
|
|
Reporter Gene Assay Market Scope and Segmentation
Global Reporter Gene Assay Market Definition
In cell cultures, bacteria, plants, or animals, a reporter gene is a gene type that researchers assigned to the regulatory sequence of another important gene. Due to certain features, certain genes are chosen as reporters. Reporter genes can also be used to measure a gene's potential protein-producing gene's expression.
Global Reporter Gene Assay Market Dynamics
Drivers
- Growing preference for cell-based assays
The growing preference for cell-based assays is one of the major factors driving the growth of the reporter gene assay market. This is due to the increased use of reported gene assays in life science research and bio manufacturing. Reporter gene assays are an important experimental tool for studying the biochemistry and physiology of both healthy and diseased cells. As a result, reporter gene assays have received a lot of attention in terms of studying emerging infectious viruses and developing drug therapies. These are the certain factors which propels the growth of the market.
- Rising prevalence of chronic genetic disorders
The rising prevalence of chronic genetic disorders and infectious diseases in the population has increased demand for reporter gene assays due to cell-based drug discovery applications. Chronic diseases, such as cancer, are one of the leading causes of death worldwide, accounting for nearly one in every six deaths in 2020, according to a World Health Organization report from 2022. According to a report published in January 2020 by the National Human Genome Research Institute, more than 6,800 rare diseases affect an estimated 25 to 30 million Americans. As a result, rising incidences of rare and genetic disorders, combined with rising demand for early diagnosis and effective treatment processes, are expected to drive market growth.
Opportunities
- Government initiatives will drive the growth
Strategic initiatives undertaken by market participants and governments are expected to propel market growth. For instance, in December 2021, Novartis acquired the entire share capital of Gyroscope Therapeutics, a UK-based ocular gene therapy company. Novartis was able to expand its portfolio into gene therapy as a result of this acquisition. As a result of the above-mentioned factors, the market is expected to grow over the forecast period.
Restraints/Challenges
- High cost of cell biology research
The high cost of cell biology research, a lack of skilled researchers, a lack of modern healthcare infrastructure in developing countries, and a lack of awareness may limit the global growth of the reporter gene assay market.
This reporter gene assay market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the reporter gene assay market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Reporter Gene Assay Market Scope
The reporter gene assay market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Assay Kits
- Reagents
Application
- Gene Regulation
- Protein Interaction
- Cell Signalling Pathways
End User
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- CROs
Reporter Gene Assay Market Regional Analysis
The reporter gene assay market is analyzed and market size insights and trends are provided by country, product, application and end user as referenced above.
The countries covered in the reporter gene assay market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the reporter gene assay market because of the initiatives taken by healthcare facilities and biotechnology businesses to speed the use of gene treatments. Additionally, the presence of numerous molecular imaging systems led by academic and research institutions is likely to accelerate the demand for reporter gene assays used for molecular imaging, which will further accelerate the growth of the reporter gene assay market in the region over the course of the forecast period.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2024 to 2032 because of the large customer base, increase in the incidences of hereditary disorders, enhancements in healthcare facilities, and enhanced per capita income.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Reporter Gene Assay Market Share
The reporter gene assay market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to reporter gene assay market.
Reporter Gene Assay Market Leaders Operating in the Market Are:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc (U.S.)
- Promega Corporation (U.S.)
- PerkinElmer Inc. (U.S.)
- Abcam plc. (U.K.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Danaher (U.S.)
- Biotium (U.S.)
- PromoCell GmbH (Germany)
- InvivoGen (U.S.)
- Geno Technology Inc. (India)
- GeneCopoeia, Inc. (U.S.)
- Lonza (Switzerland)
- General Electric (U.S.)
- QIAGEN (Germany)
- Sartorius AG (Germany)
- Berthold Technologies GmbH & Co. KG (Germany)
- Marker Gene Technologies, Inc. (U.S.)
Latest Developments in Reporter Gene Assay Market
- In November 2021, Asuragen, Inc., a Bio-Techne brand, launched a new kit to detect pathogenic variants in the CFTR gene, the AmplideX PCR/CE CFTR kit, for research use only. It covers a larger proportion of the diverse US population than any other commercially available targeted CFTR testing assay. Such products, which are primarily aimed at the American market, are also propelling market growth.
- In December 2020, Taysha Gene Therapies, Inc. signed a lease agreement to occupy and configure a commercial-scale current Good Manufacturing Practices (cGMP) manufacturing facility in Durham, North Carolina for preclinical, clinical, and commercial production of its gene therapy pipeline.
SKU-